Repeated Fecal Occult Blood Test Positivity Is Associated With Clinically Significant Colonoscopic Findings
The European Research Journal · 2026-12-01 · 1408-1415
DOI: 10.18621/eurj.1295 ↗Abstract
Objective: To evaluate the association between repeated guaiac-based fecal occult blood test (gFOBT) positivity and clinically significant colonoscopic and histopathological findings, particularly colorectal malignancy. Methods: This retrospective, single-center cohort study included patients with positive gFOBT results at the Gastroenterology Outpatient Clinic of Gazi University Faculty of Medicine between June 2017 and October 2025. Patients were categorized into 3 groups based on gFOBT results: single positive (Group 1), 2 consecutive positive tests within 1 month (Group 2), and an initial positive followed by a negative test within 1 month (Group 3). Colonoscopic and histopathological findings were compared between groups. Multivariable logistic regression analysis was conducted to identify independent predictors of malignant pathology. Results: Of 1442 patients with positive gFOBT results, 735 (50.9%) underwent diagnostic colonoscopy. Colorectal malignancy was detected in 55 patients (7.5%) undergoing colonoscopy. Malignancy rates differed significantly among groups: 5.1% in Group 1, 17.4% in Group 2, and 0% in Group 3 (P < .001). Repeated gFOBT positivity was independently associated with malignant findings (odds ratio [OR], 3.68; 95% CI, 2.03 to 6.69; P < .001). Normal findings were significantly more frequent in patients with a single positive test, whereas malignant findings were markedly higher in patients with repeated positivity. Conclusions: Repeated gFOBT positivity is strongly associated with clinically significant colonoscopic pathology, particularly colorectal malignancy. Patients with consecutive positive gFOBT results represent a high-risk subgroup and should be prioritized for prompt diagnostic colonoscopy within colorectal cancer screening programs.
EUVIMED